India, Feb. 26 -- image credit- shutterstock

Ahmedabad-based Zydus, a leading, discovery-based, global pharmaceutical company, is readyto launch the season's first India's Flu protection as per WHO recommended composition of quadrivalent influenza virus vaccines for use in the 2025 southern hemisphere.

The company'sQuadrivalent Inactivated Influenza vaccine VaxiFlu-4 will offer protection againstA/Victoria/4897/2022 (H1N1)pdm09-like virus, A/Croatia/10136RV/2023 (H3N2)-like virus, B/Austria/1359417/2021 (B/Victoria lineage)-like virus, B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

A quadrivalent vaccine, by covering strains of both influenza A and influenza B, provides a broader protection and significantly reduces the risk of va...